NASDAQ Biotechnology Index

NASDAQ Biotechnology Index — американский фондовый индекс. Индекс составляют биотехнологические и фармацевтические компании, чьи акции торгуются на бирже NASDAQ.

Критерии

Критерии включения в NASDAQ Biotechnology Index:

	Компания должна иметь листинг на бирже NASDAQ.

	Компания должна относиться либо к биотехнологической, либо к фармацевтической отрасли.

	Компания не должна быть в процессе банкротства.

	Рыночная капитализация не менее $200 млн.

	Средний ежедневный объём торгов — 100 тысяч акций.

	Акции компании должны котироваться на биржах не менее 6 месяцев

Компоненты

В индекс входят следующие компании:

	Acorda Therapeutics Inc. (NASDAQ: ACOR)

	Adolor Corporation (NASDAQ: ADLR)

	Affymetrix Inc. (NASDAQ: AFFX)

	Akorn Inc. (NASDAQ: AKRX)

	Albany Molecular Research Inc. (NASDAQ: AMRI)

	Alexion Pharmaceuticals Inc. (NASDAQ: ALXN)

	Alexza Pharmaceuticals Inc. (NASDAQ: ALXA)

	Alkermes Inc. (NASDAQ: ALKS)

	Allos Therapeutics Inc. (NASDAQ: ALTH)

	Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY)

	AMAG Pharmaceuticals Inc. (NASDAQ: AMAG)

	Amgen Inc. (NASDAQ: AMGN)

	Amylin Pharmaceuticals Inc. (NASDAQ: AMLN)

	Arena Pharmaceuticals Inc. (NASDAQ: ARNA)

	ARIAD Pharmaceuticals Inc. (NASDAQ: ARIA)

	ArQule Inc. (NASDAQ: ARQL)

	Array BioPharma Inc. (NASDAQ: ARRY)

	Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL)

	BioCryst Pharmaceuticals Inc. (NASDAQ: BCRX)

	Biodel Inc. (NASDAQ: BIOD)

	Biogen Idec Inc. (NASDAQ: BIIB)

	BioMarin Pharmaceutical Inc. (NASDAQ: BMRN)

	BioMimetic Therapeutics Inc. (NASDAQ: BMTI)

	BMP Sunstone Corporation (NASDAQ: BJGP)

	Cadence Pharmaceuticals Inc. (NASDAQ: CADX)

	Cardiome Pharma Corporation (NASDAQ: CRME)

	Celera Corporation (NASDAQ: CRA)

	Celgene Corporation (NASDAQ: CELG)

	Cephalon Inc. (NASDAQ: CEPH)

	Columbia Laboratories Inc. (NASDAQ: CBRX)

	Crucell NV (NASDAQ: CRXL)

	Cubist Pharmaceuticals Inc. (NASDAQ: CBST)

	Cypress Bioscience Inc. (NASDAQ: CYPB)

	Cytokinetics Incorporated (NASDAQ: CYTK)

	Dendreon Corporation (NASDAQ: DNDN)

	DepoMed Inc. (NASDAQ: DEPO)

	Discovery Laboratories Inc. (NASDAQ: DSCO)

	Durect Corporation (NASDAQ: DRRX)

	Dyax Corporation (NASDAQ: DYAX)

	Endo Pharmaceuticals Holdings Inc. (NASDAQ: ENDP)

	Enzon Pharmaceuticals Inc. (NASDAQ: ENZN)

	Exelixis Inc. (NASDAQ: EXEL)

	Facet Biotech Corporation (NASDAQ: FACT)

	Flamel Technologies S.A. (NASDAQ: FLML)

	Gen-Probe Incorporated (NASDAQ: GPRO)

	Genomic Health Inc. (NASDAQ: GHDX)

	Genzyme Corporation (NASDAQ: GENZ)

	Geron Corporation (NASDAQ: GERN)

	Gilead Sciences Inc. (NASDAQ: GILD)

	GTx Inc. (NASDAQ: GTXI)

	Halozyme Therapeutics Inc. (NASDAQ: HALO)

	Human Genome Sciences Inc. (NASDAQ: HGSI)

	Idenix Pharmaceuticals Inc. (NASDAQ: IDIX)

	Illumina Inc. (NASDAQ: ILMN)

	ImmunoGen Inc. (NASDAQ: IMGN)

	Immunomedics Inc. (NASDAQ: IMMU)

	Impax Laboratories Inc. (NASDAQ: IPXL)

	Incyte Corporation (NASDAQ: INCY)

	Inspire Pharmaceuticals Inc. (NASDAQ: ISPH)

	InterMune Inc. (NASDAQ: ITMN)

	Isis Pharmaceuticals Inc. (NASDAQ: ISIS)

	Lexicon Pharmaceuticals Inc. (NASDAQ: LXRX)

	Life Technologies Corporation (NASDAQ: LIFE)

	Ligand Pharmaceuticals Incorporated (NASDAQ: LGND)

	Luminex Corporation (NASDAQ: LMNX)

	MannKind Corporation (NASDAQ: MNKD)

	Matrixx Initiatives Inc. (NASDAQ: MTXX)

	Maxygen Inc. (NASDAQ: MAXY)

	Medarex Inc. (NASDAQ: MEDX)

	Medivation Inc. (NASDAQ: MDVN)

	Micromet Inc. (NASDAQ: MITI)

	MiddleBrook Pharmaceuticals Inc. (NASDAQ: MBRK)

	Momenta Pharmaceuticals Inc. (NASDAQ: MNTA)

	Mylan Inc. (NASDAQ: MYL)

	Myriad Genetics Inc. (NASDAQ: MYGN)

	Nabi Biopharmaceuticals (NASDAQ: NABI)

	Nektar Therapeutics (NASDAQ: NKTR)

	Neurocrine Biosciences Inc. (NASDAQ: NBIX)

	Novavax Inc. (NASDAQ: NVAX)

	Noven Pharmaceuticals Inc. (NASDAQ: NOVN)

	NPS Pharmaceuticals Inc. (NASDAQ: NPSP)

	Obagi Medical Products Inc. (NASDAQ: OMPI)

	ONYX Pharmaceuticals Inc. (NASDAQ: ONXX)

	Optimer Pharmaceuticals Inc. (NASDAQ: OPTR)

	Orexigen Therapeutics Inc. (NASDAQ: OREX)

	OSI Pharmaceuticals Inc. (NASDAQ: OSIP)

	Osiris Therapeutics Inc. (NASDAQ: OSIR)

	Pain Therapeutics (NASDAQ: PTIE)

	PDL BioPharma Inc. (NASDAQ: PDLI)

	Perrigo Company (NASDAQ: PRGO)

	Pharmasset Inc. (NASDAQ: VRUS)

	Pozen Inc. (NASDAQ: POZN)

	Progenics Pharmaceuticals Inc. (NASDAQ: PGNX)

	Qiagen N.V. (NASDAQ: QGEN)

	QLT Inc. (NASDAQ: QLTI)

	Questcor Pharmaceuticals Inc. (NASDAQ: QCOR)

	Regeneron Pharmaceuticals Inc. (NASDAQ: REGN)

	Rigel Pharmaceuticals Inc. (NASDAQ: RIGL)

	Salix Pharmaceuticals Ltd. (NASDAQ: SLXP)

	Sangamo BioSciences Inc. (NASDAQ: SGMO)

	Santarus Inc. (NASDAQ: SNTS)

	Savient Pharmaceuticals Inc (NASDAQ: SVNT)

	Seattle Genetics Inc. (NASDAQ: SGEN)

	Sepracor Inc (NASDAQ: SEPR)

	Sequenom Inc. (NASDAQ: SQNM)

	Shire plc (NASDAQ: SHPGY)

	StemCells Inc. (NASDAQ: STEM)

	SuperGen Inc. (NASDAQ: SUPG)

	Synta Pharmaceuticals Corp. (NASDAQ: SNTA)

	Techne Corporation (NASDAQ: TECH)

	Teva Pharmaceutical Industries Limited (NASDAQ: TEVA)

	The Medicines Company (NASDAQ: MDCO)

	Theravance Inc. (NASDAQ: THRX)

	United Therapeutics Corporation (NASDAQ: UTHR)

	Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX)

	ViroPharma Incorporated (NASDAQ: VPHM)

	Vivus Inc. (NASDAQ: VVUS)

	Warner Chilcott Limited (NASDAQ: WCRX)

	XenoPort Inc. (NASDAQ: XNPT)

	XOMA Ltd. (NASDAQ: XOMA)

	ZymoGenetics Inc. (NASDAQ: ZGEN)

Источник: http://ru.wikipedia.org/wiki/NASDAQ_Biotechnology_Index